Please select another video.
FDA approves first at-home genetic test to assess breast cancer risk
The kit from the company 23andMe tests for three mutations and is available without a prescription — though the test has limitations and it is recommended that the results are confirmed with a doctor.
Full Episodes of Nightly News
Watch full episodes of NBC’s Nightly News with Lester Holt.
Keeping you Healthy
Stay up-to-date on the latest health and medical news.
The Price You Pay
Stay up-to-date on the latest consumer and business news.
Watch long form and extended pieces from the NBC Nightly News team.